Growth Opportunity Alacrita is expanding advisory services in biotech investment and fundraising with a recent partner appointment, presenting a cross-sell opportunity to clients seeking capital strategy, due diligence support, and market engagement guidance.

Strategic Partnerships With a broad network of over 350 industry professionals and capabilities spanning preclinical to commercialization, there is potential to partner on due diligence, asset scouting, and licensing deals for pharma and biotech companies seeking external expert evaluation.

Global Expertise Consistent leadership promotions in London and North America indicate a strong transatlantic footprint; target multinational biotech firms needing cross-border regulatory, clinical, and commercialization strategy support.

End-to-End Services Alacrita offers integrated product, enterprise, and business development services, enabling cross-sell to clients requiring technology platform strategy, fundraising assistance, and partner/licensing advisory within a single engagement.

Market Positioning Positioned as an expert witness and decision-support partner across R&D and commercialization, Alacrita can pursue opportunities with biotech firms facing the valley of death, offering risk mitigation and evidence-driven development plans.